Capital World Investors lowered its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 11.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,635,080 shares of the semiconductor company’s stock after selling 868,907 shares during the quarter. Capital World Investors owned 3.47% of Synopsys worth $3,116,708,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently made changes to their positions in SNPS. Vanguard Group Inc. raised its position in shares of Synopsys by 20.7% during the 3rd quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock valued at $8,970,415,000 after buying an additional 3,120,401 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of Synopsys by 238.8% during the 3rd quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company’s stock valued at $1,393,506,000 after buying an additional 1,990,608 shares in the last quarter. Coatue Management LLC purchased a new stake in shares of Synopsys during the 3rd quarter valued at $892,605,000. Capital Research Global Investors raised its position in shares of Synopsys by 226.6% during the 3rd quarter. Capital Research Global Investors now owns 2,524,512 shares of the semiconductor company’s stock valued at $1,245,533,000 after buying an additional 1,751,432 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of Synopsys during the 4th quarter valued at $730,197,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Synopsys Price Performance
Shares of Synopsys stock opened at $464.85 on Friday. The firm has a market cap of $89.01 billion, a PE ratio of 107.60, a price-to-earnings-growth ratio of 2.83 and a beta of 1.22. Synopsys, Inc. has a 12-month low of $376.18 and a 12-month high of $651.73. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The company’s fifty day simple moving average is $466.55 and its two-hundred day simple moving average is $457.80.
Analyst Ratings Changes
SNPS has been the topic of several recent research reports. Morgan Stanley increased their target price on shares of Synopsys from $480.00 to $525.00 and gave the company an “equal weight” rating in a report on Thursday, May 28th. The Goldman Sachs Group set a $600.00 price objective on Synopsys and gave the company a “buy” rating in a research note on Wednesday, February 25th. Bank of America raised their price objective on Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Citigroup raised their price objective on Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Finally, HSBC cut Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price objective on the stock. in a research note on Friday, February 20th. Nine equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $563.81.
View Our Latest Analysis on Synopsys
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
